BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Topics
» Immuno-oncology, BioWorld Science
Immuno-oncology, BioWorld Science
RSS
Techniclone advancing development of Tumor Necrosis Therapy into phase II
Sep. 2, 1998
Pivotal clinical trial data for rituximab published
Aug. 28, 1998
Imutec receives patent protection for Virulizin in Canada
Aug. 24, 1998
Available from NIH: immunotoxin for the treatment of ovarian cancer and mesotheliomas
Aug. 20, 1998
BLP25 cancer vaccine enters phase I testing in patients with NSCLC
Aug. 19, 1998
Canadian patent covers Jenner's cancer vaccine
Aug. 13, 1998
Avax to begin pivotal trial with M-Vax in melanoma patients
July 31, 1998
MabThera now available for non-Hodgkin's lymphoma in the U.K.
July 23, 1998
FDA grants second orphan drug designation for ImmTher
July 20, 1998
Medarex begins clinical trials of Bispecific antibody for cancer
July 20, 1998
Previous
1
2
…
952
953
954
955
956
957
958
959
960
…
984
985
Next
RSS